These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 7716263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.
    Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J, Peters LJ.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1371-9. PubMed ID: 7635777
    [Abstract] [Full Text] [Related]

  • 3. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
    Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D.
    Radiother Oncol; 2000 May 30; 55(2):179-86. PubMed ID: 10799730
    [Abstract] [Full Text] [Related]

  • 4. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity.
    Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH.
    Lancet; 1992 Jun 27; 339(8809):1570-1. PubMed ID: 1351551
    [Abstract] [Full Text] [Related]

  • 5. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed.
    Dikomey E, Borgmann K, Peacock J, Jung H.
    Int J Radiat Oncol Biol Phys; 2003 Jul 15; 56(4):1194-200. PubMed ID: 12829159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
    Mackay RI, Hendry JH.
    Radiother Oncol; 1999 Jan 15; 50(1):67-75. PubMed ID: 10225559
    [Abstract] [Full Text] [Related]

  • 11. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
    Alsbeih G, Malone S, Lochrin C, Girard A, Fertil B, Raaphorst GP.
    Int J Radiat Oncol Biol Phys; 2000 Jan 01; 46(1):143-52. PubMed ID: 10656386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
    Johansen J, Bentzen SM, Overgaard J, Overgaard M.
    Radiother Oncol; 1996 Aug 01; 40(2):101-9. PubMed ID: 8884963
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation.
    Geara FB, Peters LJ, Ang KK, Wike JL, Sivon SS, Guttenberger R, Callender DL, Malaise EP, Brock WA.
    Cancer Res; 1992 Nov 15; 52(22):6348-52. PubMed ID: 1423281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.